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IN a previous paper (Hewitt, 1953) a method for the preparation and titration
of single-cell suspensions of Sarcoma 37 was described. When 4-6-week-old
mice of an albino strain which was not genetically homogeneous were used for
the titrations, an average TD50 value of 1600 presumed viable S37 cells was
obtained. This is to say that about 1.600 cells were required to give palpable
tumours in half the inoculated subcutaneous sites of inoculation. This average
value was much higher than the TD50 values obtained from titrations of a C3H
sarcoma in C3H mice (i.e., about 25 cells). It was concluded that the relatively
high TD50 values obtained for S37 were owing to genetic differences between the
tumour and the hosts to which it was transplanted. Since the genetic consti-
tution of the mouse in which S37 arose must remain unknown, it is impossible
to examine this conclusion by titrating the tumour within a genetically homo-
geneous system. On the other hand it is necessary to exclude certain other
factors which could be responsible for the relatively high TD50 levels obtained
for S37 in adult mice.
Fischer (1935) found that S37 could not be cultivated in vitro; Lasnitzki
(1952) found that a high proportion of S37 ascitic cells underwent transformation
from a round to a spindle form in vitro, and that the transformed cells did not
subsequently divide. These findings suggest the possibility that the high TD50
values obtained for S37 may result, not from the action of inhibitory factors in
the host, but from an intrinsic incapacity to divide that is common to the majority
of cells in both the solid and the ascitic tumours.
It was considered that if natural immunity were responsible for the high
TD50 values obtained in mature mice of the strain used, then the TD50 should
vary with the age of the animals used for the titration. Natural immunity is
subject to a maturation factor, and should be quite low in new-born mice. Chick
embryos do not react to chorio-allantoic grafts of mammalian tissue until 2 to
3 days before hatching, by which time the chicks are in an advanced state of
development. Mice, by comparison, are considerably more immature at birth,
and it is probable that natural immunity, as distinct from passive immunity
acquired from the mother, should be absent or very low at birth.
This paper is an account of the effect of age of host on the quantitative
transplantation ofS37 to mice ofa strain, allthe adults ofwhichwillgrowpalpable
tumours from large inocula. The results have been compared with similar data
obtained from the titration of a C3H sarcoma in C3H mice and with quantitative
data reported by other workers for different tumours.AGE OF HOST AND TRANSPLANTATION OF SARCOmA 37
MATERIALS AND METHODS.
S37 was maintained as ascites tumours by serial intraperitoneal passage.
All mice were of an albino stock which was not genetically pure, and which
had been used extensively in quantitative S37 experiments described elsewhere
(Hewitt, 1953).
The methods of preparing, counting and titrating single-cell suspensions of
viable sarcoma cells have been described in detail in a previous paper (Hewitt,
1953). Each cell dose inoculated in new-born mice was in a volume of 005
ml., the inoculations being made with a tuberculin syringe carrying a Schick
needle. Each mouse received 4 subcutaneous inoculations of the appropriate
celldose, oneineachaxilla andoneineachgroin. Thenew-born micewereallowed
to remain with their mothers throughout the experiments. They were anaes-
thetised with ether to facilitate accurate placing of the inocula, but were allowed
to recover completely from the anaesthetic before being returned to their mothers.
EXPERIMENTS AND RESULTS.
In Fig. 1 the points plotted represent the percentage incidence of palpable
tumours from inocula containing various numbers of viable tumour cells (ex-
pressed logarithmically) calculated from the cell count of a dense suspension and
the dilution factor. The points shown were obtained from the data of various
experiments. Although the points are insufficient in number and accuracy to
disclose the true character ofthe curverelatinglog. celldose and tumourincidence,
they serve to show the general trend ofthe relationship.
Litters born to mothers which had been rendered completely resistant to
S37 by their having regressed a tumour before pregnancy ensued gave results
which did not depart appreciably from those indicated in the graph.
The TD50, read from the graph, is approximately 9 viable tumour cells. This
figure is less than that obtained for the titration of C3H sarcoma in C3H mice
over one year old, that is, 18 viable cells.
Certain technicaldifficulties have theeffect ofreducing the observedpercentage
oftumours obtained from specified cell doses below the maximum value. Owing
to the fact that the tumours which form in the suckling mice quickly reach a size
which jeopardises health and movements, some animals die with tumours in 2
or 3 of the inoculated sites before all sites have been observed for a sufficiently
long period to exclude tumour formation in them. The incidence of tumours
recorded for any group thus tends to be submaximal. A further difficulty is
that a proportion of each inoculum volume often exudes from the needle track
after withdrawl of the needle. Cell counts and volume measurements of the
exuded fluid have shown that a quarter or more of the inoculated cells are lost
in this way. If these known errors were to be eliminated, the points in the
graph would be shifted slightly upward and to the left of their present positions,
and the TD50 would be rather lower than is obtained from the results as they
stand.
The effect of the diluent on the activity of sarcoma cells in dilute suspensions.
Craigie (1949), discussing various technical requirements for the quantitative
transplantation of tumour cells, drew attention to the inimical effects of various
385H. B. HEWITT
diluents upon the viability of tumour cells. In a later paper (Craigie, Lind,
Hayward, and Begg, 1951) an account was given of certain atypical cells which
composed about 5 per cent. of the tumour cells in undiluted S37 ascitic fluid.
These cells were distinguishable from the modal cells when seen by a specified
system of phase-contrast illumination, and the term " paramorphic " was pro-
posed for them. Although displaying an exceptional resistance to certain en-
vironmental conditions, paramorphic cells sustained lethal damage on extreme
dilution in physiological salt solutions. For titrating such cells it was therefore
considered necessary to vary the cell dose by using a micrometer syringe to vary
the volume of suspension inoculated (Craigie, 1952).
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FIG. 1.-Proportion of subcutaneous sites giving palpable tumours after the inoculation
of various mean doses of viable 837 cells. Results in new-born mice. The number
beside each point is the number of sites inoculated at that dose level.
Diluents in which inoculated cells were suspended:
O Tyrode solution.
A, 0 5 per cent gelatine in Tyrode solution.
*33 per cent mouse aacitic fluid in Tyrode solution.
A 10 per cent ascitic fluid in Tyrode solution.
The suspensions used to obtain the points shown in Fig. 1 were dilutions in
various fluids, and the points have been variously signified in accordance with
the diluents used in each case (see key to Fig. 1). It will be seen that the points
are not disposed in any way which suggests a characteristic influence of any of
the diluents on the activity of the inoculated cells. The points below the 25
per cent level were obtained from the inoculation of 0 05 ml. volumes of ascitic
fluid which had been diluted over one million times in a medium consisting of
0.5 per cent gelatine in Tyrode solution, finalpH 7*3-7*4. Successful transplanta-
tion using such extremely diluted suspensions, and failure to demonstrate any
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advantage of slightly diluted ascitic fluid, indicates that paramorphic cells could
have had no paramount influence in the results obtained. It can be inferred also
that the gelatine-tyrode medium is not less adequate as a diluent than a 3-fold
dilution of ascitic fluid in Tyrode solution.
Rate of loss of high sWsceptibility of new-born mice with maturation.
A counted sample of S37 malignant ascitic fluid was diluted in 0-5 per cent
gelatine in Tyrode solution to contain about 100 viable S37 cells in 0 05 ml.
(the inoculum volume).
Single litters of various ages were selected at random from the albino mouse
stock, and each mouse received four subcutaneous inocula of the diluted cell
suspension in the usual four subcutaneous sites. The order of inoculation was
so arranged that the interval elapsing between the time of preparation of the
dilute suspension and the average time at which the mice of any litter were in-
oculated was equal for all the litters. The sites were examined for palpable
tumours for a maximum period of 30 days. Some mice of the youngest litters
had to be sacrificed before 30 days, and the tumour incidence recorded for their
groups thus tended to be submaximal; the incidence for the older mice was not
subject to this error.
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FIG. 2.-Proportion of inoculated sites giving rise to palpable tumours for mice of various
ages. The average number of viable S37 cells inoculated was 100 in each case. The
number beside each point is the number of sites inoculated at that age level.
In Fig. 2 the incidence of tumours in sites receiving a viable S37 cell dose of
100 is shown for mice of various ages. It will be seen that resistance increases
quite rapidly within the first week after birth and subsequently increases more
gradually.
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Quantitative transplantation of S37 in mature mice of different age-groups.
A single-cell suspension of S37 was titrated in three series of mice, all from
the same albino stock that provided the new-born mice and belonging to the
following age-groups: 18-25 days; 143-174 days; 268-296 days. Each series
consisted of 6 groups of 3-4 mice. The incidence of palpable tumours in the
inoculated sites was recorded for a period of 27 days following inoculation.
In Table I the TD50 value given by each series is given together with its
limits of error. The TD50 and its error were calculated from the titration data
by the method ofIrwin and Cheeseman (1939), and the limits oferror in each case
were obtained from a value 3 x S.E.
TABLE I.-TD50 Values given by Mice of Various Age Groups. S37.
Age range of TD50 (viable Limits of
mice (days). tumour cells). error of TD50.
18- 25 . . 479 . . (104-2203)
143-174 . . 4677 . . (1200-18,240)
268-296 . . 1230 . . (286-5290)
It will be seen from these results that the youngest mice gave a TD50 which
is significantly lower than that for the mice of intermediate age. The difference
between the youngest and the oldest mice is not significant, but the TD50 given
by the oldest mice is considerably lower than that given by the mice of inter-
mediate age. This last different, however, does not attain a significant level by
the Irwin and Cheeseman (1939) test. When the total incidences of tumours in
all the inoculated sites were worked out for each series and tested for significant
differences by calculating %2, it was found that the incidence in the mice of
intermediate age was significantly lower than that in either the youngest mice
(p =< 0 001) or the oldest mice (p 0002-005). There was no significant
difference between the incidences in the oldest and youngest mice (p = 1-0).
It is concluded from these results that quantitative resistance to S37 is very
low at birth, rises to a peak during the period offull physiological maturity, and
subsequently tends to decline.
DISCUSSION.
The fact that imnmature animals generally show a considerably higher suscepti-
bility to infective agents than adults is widely recognised. Duran-Reynals
(1946), reviewing studies of the influence of age of host on infection, distin-
guishes the effect of maturation upon the susceptibility of the cell to infection,
and upon the development of the general systemnic processes by which an animal
manifests resistance to foreign biological material. With cellular susceptibility
we are not here concerned. The systemic mechanisms by which resistance is
manifested are cellular and humoral. In the case of resistance to tissue grafts,
it appears that cellsprimarilyare concernedintheresistancemnechanisms (Murphy,
1926). Humoral antibodies against tissue, though demonstrable, have not been
shown to play any part in resistance to homologous grafting, either in skin trans-
plantation between rabbits (Medawar, 1948) orin tumour transplantation between
different strains of mice (Barrett, 1952). Most, if not all, attempts to transfer
resistance against homologous tumours passively by the inoculation of serum from
resistant animals have failed. Mitchison (1953), for example, was Able to transfer
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immunity using lymph nodes but not using serum or peritoneal exudate. Young
mice would therefore not be expected to possess resistance against a homologous
tumour by virtue of maternal serum factors reaching them by the transplacental
route before birth or by the colostrum after birth. In the course of the present
studies it has been observed that a litter from a mother which was completely
resistant to S37, a tumour having regressed in her before pregnancy ensued, showed
the same high susceptibility as the litters ofnormal mothers. The gross develop-
ment of the lymphatic system appears to be quite advanced in new-born animals
as indicated by the presence of the thymus and by the existence of lymphocytes
in the circulation. Ifit is assumed that the lymphocyte is responsible for tumour
immunity, then the low resistance of new-born mice must be ascribed to func-
tional immaturity of the lymphatic system.
The TD50 given by the titration of S37 in new-born mice, as will be seen fronm
Fig. 1, is about 9 viable sarcoma cells. The trend of the points shown in the
graph suggests that the percentage of tumours to be expected from an average
inoculum of 1 viable cell is about 7. It is of interest to note that Furth and
Kahn (1937) succeeded in transplanting leukaemia to about 5 per cent. of their
inbred mice by the intravenous inoculation of a single leukaemic cell. Kahn
and Furth (1938) obtained only about 20 per cent of tumours from subcutaneous
sites inoculated with 50-100 viable sarcoma cells in circumstances where there
was no genetic difference between the animal in which the tumour arose and
those to which it was transplanted. A C3H sarcoma gave a TD50 of 18 viable
tumour cells when titrated in old C3H mice (Hewitt, 1953). It is evident from
these comparisons that the results of quantitative transplantation of S37 in new-
born mice of a heterogeneous strain of which the adults exhibit some resistance
to small inocula, are compared with those obtained for similar tumours within a
genetically homogeneous tumour-host system. The use of new-born mice there-
fore provides a more uniform and more sensitive system for the detection or
assay of viable tumour cells in circumstances where, owing to limited facilities
or to the use ofgenetically unknown tumours, a genetically homogeneous system
cannot be achieved.
It will be seen from Fig. 2, however, that quantitative resistance increases
perceptibly within the first week oflife. This being so, it is likely that very differ-
ent quantitative results would be obtained from the titration in new-born mice
oftumours with a slower growth rate than S37. In these circumstances resistance
factors could produce their effects before the tumours became palpable. A
lymphoma which occurred spontaneously in a mouse of the albino strain used in
these experiments gave a TD50 of over 10,000 viable cells when titrated in new-
born mice; Krebs' carcinoma ascitic cells gave a TD50 of over 2000 viable cells.
It must be concluded from the results of titrating S37 in new-born mice that
the high TD50 levels obtained in adult mice of the same stock (i.e., about 1600)
were due to immunity factors and not to intrinsic limitations of the proliferative
power of the cells.
An estimate can be made of the proportion of inoculated S37 cells which are
capable of continued proliferation if it is assumed that such cells are not subject
to any hazard affecting their proliferation once they have been successfully
deposited in the host tissues. In these circumstances the dose-response curve
would represent the chances of getting one or more " taking units " in random
samples (inocula) taken from suspensions containing different mean densities of
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" taking units." When, as here, the conditions of sampling justify the use of
the Poisson series, the chances of obtaining at random a sample (inoculum)
containing no " taking unit" is connected by a calculable relation with the mean
number of such units per sample in the suspension. This chance is given as
e-m, where m is the mean number of units per sample (Fisher, 1950). When
m = 1, e-m = 37 per cent. From Fig. 1, a suspension which gives 37 per cent
of negative sites (63 per cent of takes) contained a mean density of about 17
tumour cells per inoculum, and this evidently constitutes a single "taking unit."
Thus, when it is assumed that there are no influences at the inoculated site which
inhibit continued proliferation of a cell intrinsically capable of giving rise to a
palpable tumour, then the results reported indicate that such cells are present
in a proportion of about 1: 17 (6 per cent) of the population of cells designated
as living S37 cells on the grounds of their resistance to staining with trypan blue
and their diameters (> 9,). The frequency with which abnormal mitoses and
cellular pleomorphy are found in rapidly growing tumours would seem to indicate
that there may be a continuous production of cells which, though alive, are
intrinsically incapable of indefinite proliferation. Various observations have been
made which suggest that this is the case. Fischer (1935) was unable to cultivate
solid S37 in vitro, and concluded that dying cells exceeded living cells in this
tumour. Lasnitzki (1952) found that the majority of S37 ascites cells failed to
divide in vitro. She found also that one-third to two-thirds of the mitoses seen
in the ascitic cells in vivo were abnormal. Since it is unlikely that all mitotic
abnormalities are visible, it is possible that the proportion of mitoses which are
abnormal in vivo may reach 50 per cent. Koller and Smithers (1946) give experi-
mental proof that loss of chromosomes or of chromosome segments leads to the
death of the cell. On the other hand, there is evidence that cells with a defective
chromosome complement may survive and divide under conditions where con-
tiguity between the cells is preserved, while being unable to do so when isolated
from one another (Koller, 1947). These considerations favour the assumption
that a significant proportion of the S37 ascitic cells are unlikely to be capable of
indefinite proliferation and tumour formation. Furthermore, if the cells should
be dependent upon one another for a stimulus to divide, dilution may reduce the
proliferative power of an inoculum, not by damaging individual cells, but by
abolishing essential mutual influences between the cells. When allowance is
made for these intrinsic limitations within the transplanted inoculum, it appears
that the hazards encountered by any fully capable cell in the course of trans-
plantation may be considerably less than is often supposed.
The gradual rise in TD50 level which occurs as maturity advances and the
tendency for it to fall as senescence approaches are observations which accord
with the findings of others. Little (1920) showed that, whereas the adult mice
ofa certain strain were totallyinsusceptible to transplantation ofa certaintumour,
the tumour would take in 19 per cent of 2-10-day-old mice and in 9 per cent of
12-20-day-old mice of the same strain. Little (1941) refers to Strong's obser-
vation that tumour transplants grew better in very old mice than in mice in their
physical prime. These age changes were noted only in the case of tumours
transplanted to mice genetically different from the mouse in which the tumour
arose, and it is likely that they reflect age changes in immune responsiveness.
Although the evidence here reported shows that the number of S37 cells
required to give tumours in new-born mice of a heterogeneous strain is com-
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parable to the number of leukaemia or sarcoma cells required for successful
transplantation within a genetically homogeneous system, the results are strictly
in accordance with the supposition that cells are indispensable for successful
transfer of the tumour. They emphasise the necessity for applying scrupulous
criteria for cell exclusion in experiments designed to prove non-cellular trans-
mission of tumours. Klein (1952), for example, in experiments similar to those
ofStasney, Cantarow and Paschkis (1950), obtained tumours from the inoculation
of material believed to consist only of chromatin fragments and prepared from
transplantable lymphomas. Although cells and nuclei could not be seenin stained
smears of the inoculated material, it was found that the tumours resulting from
the inoculations had the genetic constitution ofthe mouse strain originally donat-
ing the tumour and not that of the inoculated hosts. Klein (1952) concluded
from this finding that the tumours had arisen from intact cells which had con-
taminated the fragmented material. It is clear, from the results here reported,
that microscopic examination of the whole of an actual inoculum is required if it
is to be deemed free from intact tumour cells.
SUMMARY.
1. Quantitative transplantation of S37 in new-born mice of a heterogeneous
strain gave results similar to those obtained for the transplantation of a C3H
sarcoma in adult C3H mice. The number of presumed viable tumour cells
required to give palpable tumours in half of the inoculated sites (the TD50)
was 9.
2. From the dose-response curve, it was estimated that the proportion of
viable tumour cells in S37 ascitic fluid which are capable ofgiving rise to a tumour
is between 1 in 10 and 1 in 20 when it is assumed that the inoculated cells are
subject to no hazards in the host.
3. The high susceptibility of suckling mice to very small inocula of S37 cells
falls steeply in the first week of life and subsequently more gradually.
4. Evidence that serial dilution of the cell suspensions in an artificial diluent
is not accompanied by progressive inimical effects upon the cells is given by the
production of tumours from ascitic fluid which had been diluted over one and a
halfmillion times in 0 5 per cent gelatine in Tyrode solution.
5. Mice 5-6 months old gave a TD50 level for S37 cells which was significantly
higher than that given by mice 18-25 days old or mice 9-10 months old.
6. It is suggested that the use of new-born mice for the titration of S37 cells
gives results equivalent to those obtained from titration of the cells of similar
types of tumour within a genetically homogeneous system.
7. The significance ofthe results is discussed in connection with the prolifera-
tive potentialities of individual S37 ascitic cells, and in connection with experi-
ments designed to demonstrate cell-free transmission of tumours.
I am indebted to Miss Catherine Fysh, B.Sc., for skilled technical assistance,
and to the British Empire Cancer Campaign for grants during the tenure ofwhich
these investigations were made.
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